Gland Pharma (NSE:GLAND) Operating Cash Flow per Share : ₹0.00 (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Gland Pharma Operating Cash Flow per Share?

Gland Pharma's operating cash flow per share for the three months ended in Mar. 2024 was ₹0.00. Gland Pharma's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Gland Pharma was 173.80% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 16.50% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 20.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Gland Pharma's Operating Cash Flow per Share or its related term are showing as below:

NSE:GLAND' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -19.9 Med: 31.05 Max: 61.8
Current: 16.5

During the past 7 years, Gland Pharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was 61.80% per year. The lowest was -19.90% per year. And the median was 31.05% per year.

NSE:GLAND's 3-Year OCF Growth Rate is ranked better than
62.67% of 801 companies
in the Drug Manufacturers industry
Industry Median: 7.5 vs NSE:GLAND: 16.50

Gland Pharma Operating Cash Flow per Share Historical Data

The historical data trend for Gland Pharma's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gland Pharma Operating Cash Flow per Share Chart

Gland Pharma Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Operating Cash Flow per Share

Get a 7-Day Free Trial

42.93

38.22

48.06

22.10

60.51

Gland Pharma Quarterly Data
	Mar19	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Operating Cash Flow per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Gland Pharma's Operating Cash Flow per Share

For the Drug Manufacturers - General subindustry, Gland Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gland Pharma's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gland Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Gland Pharma's Price-to-Operating-Cash-Flow falls into.

Gland Pharma Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Gland Pharma's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (A: Mar. 2024 )	=	Cash Flow from Operations (A: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (A: Mar. 2024 )
	=	9967.97	/	164.739
	=	60.51

Gland Pharma's Operating Cash Flow per Share for the quarter that ended in Mar. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2024 )	=	Cash Flow from Operations (Q: Mar. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2024 )
	=	0	/	164.743
	=	0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00

Gland Pharma Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Gland Pharma's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Gland Pharma (NSE:GLAND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gland Pharma Ltd (NSE:GLAND) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

543245:India

Address

Plot No. 11 and 84, TSIIC Phase: IV, Pashamylaram (V), Patancheru (M), Sangareddy District, Hyderabad, TG, IND, 502307

Website

https://www.glandpharma.com

Gland Pharma Ltd is engaged in the development, manufacturing, and marketing of complex injectables. The company's key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Further, the group is involved in vast range of therapeutic categories that include Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarial, Cardiology and more - to Hormones and related Drugs, Fertility Supplements and Gnrh Agonists and Antagonists. Geographically, it derives a majority of revenue from the USA.

Gland Pharma (NSE:GLAND) Headlines

No Headlines